New cancer drugs release the brakes on the immune systemEarly trials of immunotherapy mark ‘new chapter’ in oncology Guidelines for prevention of acute antineoplastic-induced nausea and vomiting in childrenPediatric Oncology Group of Ontario spearheads development of guidelines for the prevention of acute antineoplastic-induced nausea and vomiting in children. CUA: Testosterone level should guide androgen deprivation therapy Analysis shows importance of reaching low values CUA: Prostate inflammation cuts cancer risk Finding has implications for biopsy followup CUA: A new way to zap the prostate—MRI-guided laser ablation Outpatient procedure has low morbidity but high failure rate CUA: Survey reveals gaps in genitourinary cancer survivorship care Xtandi: new oral androgen receptor inhibitor for metastatic prostate cancer Drug is intended for patients who have undergone medical or surgical castration and who have received docetaxel therapy. Prostate cancer: More men can opt for active surveillance All conventional criteria need not be fulfilled, analysis shows U.S. guideline nixes prostate screening in under-55s Late toxicities of cancer drugs Cardiac, pulmonary, sexual, and neurologic toxicities that develop or persist after completing cancer drug therapy First Previous 42 43 44 45 46 Next Last
